-Fox News
Novavax and SK bioscience File Post Approval Change Application In South Korea For Nuvaxovid COVID-19 Vaccine As A Booster In Adults Aged 18 And Older
https://ir.novavax.com/Switzerlands-Federal-Office-of-Public-Health-Recommends-Novavax-Nuvaxovid-TM-COVID-19-Vaccine-as-a-Booster-in-Adults-Aged-18-and-Older